THE PROGRAM OF QUALITY ASSURANCE OF THE EORTC RADIOTHERAPY GROUP - A HISTORICAL OVERVIEW

被引：40

作者：

HORIOT, JC

VANDERSCHUEREN, E

JOHANSSON, KA

BERNIER, J

BARTELINK, H

机构：

[1] UNIV HOSP ST RAFAEL,LOUVAIN,BELGIUM

[2] GOTHENBURG UNIV,SAHLGREN HOSP,GOTHENBURG,SWEDEN

[3] OSPED SAN GIOVANNI BELLINZONA,BELLINZONA,SWITZERLAND

[4] NETHERLANDS CANC INST,A VAN LEEUWENHOEK HUIS,AMSTERDAM,NETHERLANDS

来源：

RADIOTHERAPY AND ONCOLOGY | 1993年 / 29卷 / 02期

关键词：

RADIOTHERAPY; QUALITY ASSURANCE COOPERATIVE TRIALS; RADIATION;

D O I：

10.1016/0167-8140(93)90229-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A quality assurance programme was activated in 1982 in the EORTC Cooperative Group of radiotherapy. Definitions and contents of quality assurance and quality control, definitions of errors and deviations (systematic, occasional) are given. The need for an interaction between national and international networks is emphasized. Consensus statements on quality assurance in radiotherapy provided during the January 1993 Geneva meeting conclude this introduction to the detailed reports on the quality assurance programme of the EORTC Cooperative Group of Radiotherapy.

引用

页码：81 / 84

页数：4

共 12 条

[1]

ANG KK, 1982, INT J RADIAT ONCOL, V8, P1657

[2] THE CONSERVATIVE MANAGEMENT OF BREAST-CARCINOMA BY TUMORECTOMY AND RADIOTHERAPY - AN EORTC PHASE-III STUDY (22881/10882) [J].

BARTELINK, H ;

VANDERSCHUEREN, E ;

VANGLABBEKE, M ;

PIERART, M .

RADIOTHERAPY AND ONCOLOGY, 1991, 22 (04) :R5-R5

[3] IS PROPHYLACTIC PARA-AORTIC IRRADIATION WORTHWHILE IN THE TREATMENT OF ADVANCED CERVICAL-CARCINOMA - RESULTS OF A CONTROLLED CLINICAL-TRIAL OF THE EORTC RADIOTHERAPY GROUP [J].

HAIE, C ;

PEJOVIC, MH ;

GERBAULET, A ;

HORIOT, JC ;

POURQUIER, H ;

DELOUCHE, J ;

HEINZ, JF ;

BRUNE, D ;

FENTON, J ;

PIZZI, G ;

BEY, P ;

BROSSEL, R ;

PILLEMENT, P ;

VOLTERRANI, F ;

CHASSAGNE, D .

RADIOTHERAPY AND ONCOLOGY, 1988, 11 (02) :101-112

[4]

Horiot J., 1992, SEMIN RADIAT ONCOL, V2, P34, DOI [10.1016/S1053-4296(05)80050-5, DOI 10.1016/S1053-4296(05)80050-5]

[5] HYPERFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN OROPHARYNGEAL CARCINOMA - FINAL ANALYSIS OF A RANDOMIZED TRIAL OF THE EORTC COOPERATIVE GROUP OF RADIOTHERAPY [J].

HORIOT, JC ;

LEFUR, R ;

NGUYEN, T ;

CHENAL, C ;

SCHRAUB, S ;

ALFONSI, S ;

GARDANI, G ;

VANDENBOGAERT, W ;

DANCZAK, S ;

BOLLA, M ;

VANGLABBEKE, M ;

DEPAUW, M .

RADIOTHERAPY AND ONCOLOGY, 1992, 25 (04) :231-241

[6]

HORIOT JC, 1992, RADIOTHER ONCOL S, V24, pS102

[7]

HORIOT JC, 1990, B CANC RADIOTHER, V77, P299

[8] LATE RESULTS OF MULTIPLE FRACTIONS PER DAY (MFD) WITH MISONIDAZOLE IN ADVANCED CANCER OF THE HEAD AND NECK - A PILOT-STUDY OF THE EORTC RADIOTHERAPY GROUP [J].

VANDENBOGAERT, W ;

VANDERSCHUEREN, E ;

VANTONGELEN, C ;

HORIOT, JC ;

CHAPLAIN, G ;

ARCANGELI, G ;

GONZALEZ, D ;

SVOBODA, V .

RADIOTHERAPY AND ONCOLOGY, 1985, 3 (02) :139-144

[9]

1984, PHYSICAL ASPECTS QUA

[10]

1976, ICRU24 INT COMM RAD

← 1 2 →